ANAli Nazari

Ali Nazari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Nazari has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Maedeh Samianifard

    Department of Research and Development, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj

    4 shared publications
  • Abbas Zare

    Department of venomous animal, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj

    1 shared publication
  • Abbas Zare Mirakabadi

    Razi Vaccine and Serum Research Institute, Iran

    1 shared publication
  • Ali Ameghi Rodsary

    Department of Research & Development, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Marand, Iran

    1 shared publication
  • F Tahoori

    Department of Human Bacterial Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iranand Extension Organization (AREEO), Karaj, Iran

    1 shared publication
  • Fatemeh Tahoori

    Department of Human Bacterial Vaccine, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj

    1 shared publication

Latest Publications

  • Open Access

    Proteomic analysis and immunoprofiling of Persian horned viper venom, Pseudocerastes persicus from central part of Iran

    by Maedeh Samianifard, Fatemeh Tahoori, Tara Emami, Abbas Zare, Ali Nazari

    Numerous species of venomous snakes of medical importance exist in Iran. Pseudocerastes persicus one of the medically important snake that is also called the Persian horned viper, has a geographical spread that extends to the east, southwest, and central areas of the country and is endemic across the wider region. As a result, this species is responsible for a significant number of snakebite occurrences.Venom from Pseudocerastes persicus found in the central province of Semnan was found to contain phospholipase A2 and L-amino acid oxidase activities, and high toxic potency. The venom was fractionated by reverse-phase HPLC and analyzed by SDS-PAGE, Western blotting and two-dimensional electrophoresis. Using liquid chromatography with tandem mass spectrometry (LC-MS/MS), a range of components were identified, consistent with the biochemical and toxicological properties of the venom: proteins identified from 2D electrophoresis and shotgun methods included metallo- and serine proteases, phospholipases, oxidases, and Kunitz trypsin inhibitors along with many other components at lower qualitative abundance. This study provides a more detailed understanding of the protein profile of Iranian P. persicus venom, which can be effective in the production of an effective antidote against it. The analysis of the resulting data shows that there is a wide range of proteins in the venom of the Iranian Persian horned viper. This informations can provide a better understanding of how venom is neutralized by polyclonal antivenom. Considering the wide presence of this snake and its related species in Iran and surrounding countries, knowing the venom protein profile of this family can be of great support to antivenom producers such as Razi Institute in the preparation of regional antivenoms.


  • Open Access

    Authorizing of Immunogenicity of concentrated and purified Newcastle disease virus using downstream processing

    by Ali Nazari, Maedeh Samianifard, Ali Ameghi Rodsary, M.A.G Golipour, Mohsen Mahmoudzadeh, Mohammad Abdoshah

    Newcastle disease virus from the Paramyxoviridae family is a single-stranded negative-sense RNA virus. NDV is an infection of domestic poultry and nearly all bird species. It has been a very severe difficulty for the poultry industry all over the world Even though it remains a potential threat to poultry industries, this virus is a powerful oncolytic virus as well. In this study a process was accomplished to achieve concentrated and highly purified NDV V4 strain particles. Downstream processing of Newcastle virus strain V4 was characterized by amplifying virus in embryonated chicken eggs. Through a sequence of steps, harvesting allantoic fluid, clarification by centrifuge, concentration by ultrafiltration, size exclusion separation, the reduced volume and pure virus particles were considered for the amount of ovalbumin, hemagglutinin activity, electron microscopy (TEM), electrophoresis, and additionally immunogenicity of prepared antigens. The results presented a high recovery of HA activity in concentrated and pure virus with removing of ovalbumin and the typical morphology based on TEM. Sepharose CL-4B was determined as the best media among all used resins to purify the virus. Prepared formulations as vaccines demonstrated a positive hemagglutinin inhibition for 6 months duration and stable for two years. Organized study provided strong evidence that this method was quite appropriate in concentrating and purifying of intact Newcastle disease virus to use in vaccine research, also in antiserum preparation, or probably like an oncotic agent as an alternative to conventional procedures. Though additional studies are being tested, this procedure can be used practically on a semi-industrial scale in the production of multiple vaccine components.


  • Open Access

    Proteome Analysis of Toxic Fractions of Iranian Cobra (Naja naja Oxiana) Snake Venom Using Two-Dimensional Electrophoresis and Mass Spectrometry

    by M Samianifard, A Nazari, F Tahoori, N Mohamadpour Dounighi

    Snake venoms are mostly composed of various proteins and peptides with toxicity and pharmacological effects depending on their geographical sources. Naja naja oxiana is one of the most medically important venomous snakes in Iran and Central Asia. The bite of this type of snake can cause severe pain and swelling, as well as neurotoxicity. Without medical treatment, symptoms quickly worsen and death can occur soon. A detailed understanding of venom components can provide new insight into the production of antivenom against toxic agents instead of crude venom. Specific antibodies against toxic fractions are of utmost importance in neutralizing crude venom. Therefore, the proteome profile of these fractions of Naja naja oxidana venom was analyzed using fractionation by gel filtration, two-dimensional electrophoresis, mass spectrometry, and data mining. Base on the results, in total, 32 spots were detected and categorized into three protein families, namely three-finger toxin (3FTx), phospholipase, and Cysteine-rich secretory proteins (CRISP). These proteins consist of more than 70% crude venom all with a molecular weight below 25 kDa. The 3FTx as a highly diverse constituent in the venom of Naja species was in large quantity in this district. Short-chain neurotoxins, including short neurotoxin, cytotoxin, and muscarinic toxin-like protein, were in abundance, respectively. In conclusion, the recognition of toxic fractions of Naja naja oxiana in this region could be of great help in the production of an effective antivenom against similar compositions. It can also help the medical care department to find out the clinical sign of cobra venom. To the best of our knowledge, this was the first study to report the proteomic of toxic fractions of Naja naja oxiana in Iran.


  • Open Access

    Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology

    by Ali Nazari, Maedeh Samianifard, Hadi Rabie, Abbas Zare Mirakabadi

    The production of antivenom from immunized animals is an established treatment for snakebites; however, antibody phage display technology may have the capacity to delivery results more quickly and with a better match to local need. Naja oxiana, the Iranian cobra, is a medically important species, responsible for a significant number of deaths annually. This study was designed as proof of principle to determine whether recombinant antibodies with the capacity to neutralize cobra venom could be isolated by phage display. Toxic fractions from cobra venom were prepared by chromatography and used as targets in phage display to isolate recombinant antibodies from a human scFv library. Candidate antibodies were expressed in E. coli HB2151 and purified by IMAC chromatography. The selected clones were analyzed in in vivo and in vitro experiments. Venom toxicity was contained in two fractions. Around a hundred phage clones were isolated against each fraction, those showing the best promise were G12F3 and G1F4. While all chosen clones showed low but detectable neutralizing effect against Naja oxiana venom, clone G12F3 could inhibit PLA2 activity. Therefore, phage display is believed to have a good potential as an approach to the development of snake antivenom.


  • Open Access

    Bioassay of derived components from venom of Iranian medically important scorpions to identify the bradykinin potentiating factors

    by Hamid Reza Goudarzi, Ali Nazari, Mojtaba Noofeli, Maedeh Samiani

    The venom of animals, including snakes, scorpions and spiders is a complex combination of proteins, peptides, and other biomolecules as well as some minerals. Among the biomolecules, some peptides prevent converting of angiotensin 1 to angiotensin 2 by inhibiting of the Angiotensin Converting Enzyme (ACE) and finally reducing the blood pressure in the victims. The aim of the present study was to isolate venom components of the three species of Iranian medically important scorpions and to study the bradykinin potentiating effect of them. Separation of the venom components for each scorpion was carried out using high performance liquid chromatography (HPLC). The range of fractions (zones) obtained in several replicates on Guinea pig ileum and rat uterus tissues were performed using organ bath instrument. The bioassays were resulted in the peptides including Z 1 and Z 2 regions of venom chromatogram of the Hottentotta sulcyi , Z 2 for Odontobutus doriea and Z 2 and Z 3 in Mesobutus eupeus venom demonstrated bradykinin potentiating effect.


  • Open Access

    Isolation of recombinant antibodies directed against surface proteins of Clostridium difficile

    by Ali Nazari Shirvan, Robert Aitken

    Clostridium difficile has emerged as an increasingly important nosocomial pathogen and the prime causative agent of antibiotic-associated diarrhoea and pseudomembranous colitis in humans. In addition to toxins A and B, immunological studies using antisera from patients infected with C. difficile have shown that a number of other bacterial factors contribute to the pathogenesis, including surface proteins, which are responsible for adhesion, motility and other interactions with the human host. In this study, various clostridial targets, including FliC, FliD and cell wall protein 66, were expressed and purified. Phage antibody display yielded a large panel of specific recombinant antibodies, which were expressed, purified and characterised. Reactions of the recombinant antibodies with their targets were detected by enzyme-linked immunosorbent assay; and Western blotting suggested that linear rather than conformational epitopes were recognised. Binding of the recombinant antibodies to surface-layer proteins and their components showed strain specificity, with good recognition of proteins from C. difficile 630. However, no reaction was observed for strain R20291—a representative of the 027 ribotype. Binding of the recombinant antibodies to C. difficile M120 extracts indicated that a component of a surface-layer protein of this strain might possess immunoglobulin-binding activities. The recombinant antibodies against FliC and FliD proteins were able to inhibit bacterial motility.